Hematology and Oncology Board Review 2020 caused by the American Board of Internal Medicine (ABIM) certification/recertification criteria is addressed by the Brigham and Dana-Farber Board Review. In this CME session, experts will present case-based board reviews on pertinent issues. Gain the skills to:
- Improve patient care.
- Analyze complex hematologic and oncologic disorders.
- Find and use the newest hematologic and oncologic treatments.
- Analysis and interpretation of hematology and oncology literature at Hematology and Oncology Board Review 2020.
- Show knowledge of hematologic and oncologic pathogenesis.
- Master the ABIM hematology and oncology certification/recertification exams with your new knowledge.
Explore New Guidelines at Hematology and Oncology Board Review 2020:
This self-paced Hematology and Oncology Board Review 2020 course provides up to 44 AMA PRA Category 1 Credits â„¢ and 44 ABIM MOC points. This resource provides objective, research-backed information, and real-life case studies online or on audio MP3 CDs to help you comprehend and implement the latest professional suggestions.
TOPICS/SPEAKERS at Hematology and Oncology 2020:
- Molecular Genetics of Cancer –Â Nikhil Wagle, MD
- Advances in Cancer Drug Development –Â Geoffrey I. Shapiro, MD, PhD
- Infections in Cancer Patients –Â Lindsey Baden, MD
- Symptom Management in Patients with Cancer –Â Andrew J. Lawton, MD
- Communication: The Key to Excellence in End-of-Life Care –Â Rachelle E. Bernacki, MD
- Biology of Hematopoietic Stem Cell Transplantation –Â Robert J. Soiffer, MD
- Biology of Acute Leukemia and Myelodysplastic Syndromes –Â Benjamin L. Ebert, MD, PhD
- Acute Leukemias –Â Daniel J. DeAngelo, MD, PhD
- Myelodysplastic Syndrome –Â David P. Steensma, MD
- Chronic Myelogenous Leukemia –Â Marlise R. Luskin, MD
- Myeloproliferative Syndromes –Â Ann M. Mullally, MD
- Multiple Myeloma –Â Kenneth C. Anderson, MD
- Waldenstrom Macroglobulinemia and Amyloidosis –Â Jorge J. Castillo, MD
- Low-Grade Lymphomas –Â Caron A. Jacobson, MD
- High-Grade Lymphomas –Â Eric D. Jacobsen, MD
- Hodgkin’s Lymphoma –Â Jennifer L. Crombie, MD
- Diagnosis and Treatment of CLL and Related B Cell Malignancies –Â Matthew S. Davids, MD
- Head and Neck Cancer –Â Robert I. Haddad, MD
- Natural History, Screening, Surgery and Small Cell Lung Cancer –Â Bruce E. Johnson, MD
- Non-Small Cell Lung Cancer –Â Mark Awad, MD, PhD
- Mesothelioma and Thymoma –Â David M. Jackman, MD
- Thyroid Cancer –Â Jochen Lorch, MD
- Carcinoid and Pancreatic Neuroendocrine Tumors –Â Jennifer Ang Chan, MD
- Esophageal and Gastric Cancer –Â Peter C. Enzinger, MD
- Pancreatic and Hepatobiliary Cancer –Â Brian M. Wolpin, MD
- Anal Cancers –Â Robert J. Mayer, MD
- Colorectal Cancers –Â Robert J. Mayer, MD
- Gastrointestinal Cancer: Genetic Syndromes –Â Matthew Yurgelun, MD
- Germ Cell Tumor: Maximizing Cure While Minimizing the Burden of Therapy –Â Mark M. Pomerantz, MD
- Renal and Bladder Cancer –Â Guru P. Sonpavde, MBBS
- Prostate Cancer Part I: Overview and Management of Localized Disease –Â Atish D. Choudhury, MD, PhD
- Prostate Cancer Part II: Management of Disseminated Prostate Cancer –Â Atish D. Choudhury, MD, PhD
- Melanoma –Â F. Stephen Hodi, MD
- Sarcomas and Gastrointestinal Stromal Tumors (GIST) –Â George D. Demetri, MD
- Ovarian Cancer –Â Ursula A. Matulonis, MD
- Cervical and Endometrial Cancer –Â Panagiotis A. Konstantinopoulos, MD, PhD
- Neuro-oncology –Â David A. Reardon, MD
- Breast Cancer: Risk Factors, Genetics, Screening, and Prevention –Â Judy E. Garber, MD, MPH
- Multimodality Therapy for Early-Stage Breast Cancer: Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD
- Multimodality Therapy for Early-Stage Breast Cancer: Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD
- Management of Metastatic Breast Cancer –Â Erica Mayer, MD, MPH
- Breast Cancer Survivorship –Â Ann H. Partridge, MD, MPH
- Hematopoiesis and Cytokines –Â David T. Scadden, MD
- Acquired Bone Marrow Failure –Â Julie-Aurore Losman, MD, PhD
- Congenital Bone Marrow Failure –Â Akiko Shimamura, MD, PhD
- Hemophagocytic Syndromes and Related Immunodeficiencies –Â Barbara A. Degar, MD
- Anemia: An Overview –Â Ronald P. McCaffrey, MD
- Iron Deficiency and Iron Overload –Â Mark D. Fleming, MD, PhD
- Immune Hemolytic Anemia –Â Richard M. Kaufman, MD
- Non-immune Hemolytic Anemia –Â David E. Golan, PhD, MD
- Sickle Cell Disease –Â Maureen M. Achebe, MD, MPH
- Thalassemia and Other Hemoglobinopathies –Â Matthew M. Heeney, MD
- Disorders of Neutrophils –Â Nancy Berliner, MD
- Acquired Thrombocytopenias –Â Elisabeth M. Battinelli, MD, PhD
- Hemophilia –Â Aric D. Parnes, MD
- Von Willebrand Disease and Congenital Platelet Disorders –Â Nathan T. Connell, MD, MPH
- Congenital and Acquired Thrombophilia –Â Kenneth A. Bauer, MD
- Use of Direct Oral Anticoagulants in Clinical Practice –Â Jean M. Connors, MD
- Transfusion Medicine for the Clinician –Â Walter H. Dzik, MD
See Also: Hematology with 2023 Highlights of ASH in North America
Reviews
There are no reviews yet.